STOCK TITAN

Balchem Corp Stock Price, News & Analysis

BCPC Nasdaq

Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.

Balchem Corporation (NASDAQ: BCPC) is a global specialty ingredient manufacturer for health and nutrition markets, and its news flow reflects this focus. Company press releases highlight the development, manufacture and marketing of specialty ingredients that improve and enhance the health and well-being of life on the planet, as well as financial and corporate updates relevant to investors and industry observers.

Visitors to this BCPC news page can review Balchem’s announcements on quarterly financial results, dividend declarations and participation in investor conferences. Recent releases have reported segment-level performance for its Human Nutrition & Health, Animal Nutrition & Health and Specialty Products segments, along with measures such as net sales, earnings from operations, adjusted EBITDA and free cash flow, as described in accompanying Form 8-K filings.

Balchem also issues news related to regulatory and trade developments that affect its markets. For example, the company joined another EU producer in welcoming European Union anti-dumping duties on choline chloride imports from China, emphasizing the importance of fair trade for the EU food and feed supply chain and for maintaining a healthy domestic choline chloride industry.

In addition, Balchem regularly announces its participation in conferences hosted by firms such as CJS Securities, Baird, H.C. Wainwright, Wells Fargo and others, where its leadership presents to the investment community. These updates provide insight into how the company communicates its strategy and segment performance to shareholders and analysts. Investors and researchers can use this news stream to follow Balchem’s financial reporting, capital allocation decisions such as dividends, and its commentary on market and regulatory conditions affecting its human nutrition, animal nutrition and specialty products businesses.

Rhea-AI Summary

Balchem Corporation (NASDAQ: BCPC) is set to present at the Jefferies Virtual Industrials Conference on August 4, 2021, starting at 9:00 a.m. ET. The presentation will be led by Chairman and CEO Ted Harris, along with CFO Martin Bengtsson. Investors and interested parties can listen to the presentation via the provided link.

Balchem specializes in developing, manufacturing, and marketing ingredients aimed at improving health across various industries, including Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.29%
Tags
conferences
-
Rhea-AI Summary

Balchem Corporation (NASDAQ: BCPC) will hold a conference call on July 30, 2021, at 11:00 AM ET to discuss its second quarter results. The results will be published before the market opens on the same day. The conference call, hosted by Ted Harris (CEO) and Martin Bengtsson (CFO), will be available for replay until August 13, 2021. Interested parties can access the call by dialing toll-free 1-877-407-8289. More details including financial exhibits will be available on balchem.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
conferences earnings
-
Rhea-AI Summary

Balchem Corporation (NASDAQ: BCPC) will present at the Stephens Food & Ag Disrupted: Public-Private Conference on May 25, 2021, starting at 9:00 a.m. (ET). Chairman and CEO Ted Harris and CFO Martin Bengtsson will lead the presentation. Investors can follow the link to listen live: Presentation Link.

Balchem develops specialty ingredients across three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, enhancing health and well-being globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
conferences
Rhea-AI Summary

Balchem Corporation (NASDAQ: BCPC) reported strong first-quarter 2021 financial results, achieving net earnings of $23.4 million, up 18.4% year-over-year. Adjusted net earnings also rose to $28.4 million, reflecting growth across all three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Net sales increased by 6.4% to $185.7 million, with notable contributions from chelated minerals and choline nutrients. The company maintained strong cash flow, leading to $40.6 million in operational cash flow and $34.4 million in free cash flow.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.06%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Balchem Corporation (NASDAQ: BCPC) announced a conference call scheduled for April 30, 2021, at 11:00 AM ET to discuss its first quarter results. The financial results will be released before the market opens on the same day. Attendees can join the call by dialing a toll-free number and access a replay through specified numbers until May 14, 2021. Balchem operates in three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, focusing on enhancing health and well-being.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
conferences earnings
Rhea-AI Summary

Balchem Corporation (NASDAQ: BCPC) will present at the J.P. Morgan Industrials Conference on March 15, 2021. CEO Ted Harris and CFO Martin Bengtsson will lead the presentation, starting at 9:40 a.m. ET. Interested parties can follow the provided link to listen live.

Balchem specializes in developing and marketing ingredients that enhance health and well-being across various industries. Their operations are divided into three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.65%
Tags
conferences
-
Rhea-AI Summary

Balchem Corporation (NASDAQ: BCPC) reported fourth quarter 2020 net earnings of $22.2 million, a rise from $20.4 million in Q4 2019. Adjusted net earnings decreased to $26.9 million from $28.4 million. Record quarterly net sales reached $180.7 million, an increase of 8.5% year-over-year. Full-year net earnings were $84.6 million, with adjusted net earnings at $107.8 million. Strong cash flow supported debt repayments totaling $30 million in Q4 and $95 million for the year, lowering net debt to $79 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
-
Rhea-AI Summary

Balchem Corporation (NASDAQ: BCPC) will feature a presentation by Chairman and CEO Ted Harris and CFO Martin Bengtsson during a H.C. Wainwright Fireside Chat on February 24, 2021, starting at 2:00 p.m. (EDT). This event aims to showcase Balchem’s innovative solutions in the health and nutrition sectors.

Balchem develops and markets specialty ingredients across three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, focusing on enhancing health and well-being globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.87%
Tags
conferences
Rhea-AI Summary

Balchem Corporation (NASDAQ: BCPC) has scheduled a conference call for February 19, 2021, at 11:00 AM ET to discuss its fourth quarter results. The financial results will be released before the market opens on the same day. CEO Ted Harris and CFO Martin Bengtsson will lead the call, which can be accessed via toll-free number 1-877-407-8289. A replay will be available post-call until March 5, 2021. Detailed information can be found on their website at balchem.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.73%
Tags
conferences earnings

FAQ

What is the current stock price of Balchem (BCPC)?

The current stock price of Balchem (BCPC) is $169.48 as of March 31, 2026.

What is the market cap of Balchem (BCPC)?

The market cap of Balchem (BCPC) is approximately 5.5B.

BCPC Rankings

BCPC Stock Data

5.46B
31.82M
Specialty Chemicals
Chemicals & Allied Products
Link
United States
MONTVALE

BCPC RSS Feed